6.
Oppenheimer J, Nelson H, Bock S, Christensen F, Leung D
. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol. 1992; 90(2):256-62.
DOI: 10.1016/0091-6749(92)90080-l.
View
7.
Bush R, Swenson C, Fahlberg B, Evans M, Esch R, Morris M
. House dust mite sublingual immunotherapy: results of a US trial. J Allergy Clin Immunol. 2011; 127(4):974-81.e1-7.
DOI: 10.1016/j.jaci.2010.11.045.
View
8.
Creticos P, Maloney J, Bernstein D, Casale T, Kaur A, Fisher R
. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults. J Allergy Clin Immunol. 2013; 131(5):1342-9.e6.
DOI: 10.1016/j.jaci.2013.03.019.
View
9.
Dahl R, Stender A, Rak S
. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy. 2006; 61(2):185-90.
DOI: 10.1111/j.1398-9995.2005.00949.x.
View
10.
Shaikh W, Shaikh S
. A prospective study on the safety of sublingual immunotherapy in pregnancy. Allergy. 2012; 67(6):741-3.
DOI: 10.1111/j.1398-9995.2012.02815.x.
View
11.
Bozek A, Ignasiak B, Filipowska B, Jarzab J
. House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis. Clin Exp Allergy. 2013; 43(2):242-8.
DOI: 10.1111/cea.12039.
View
12.
Nolte H, Hebert J, Berman G, Gawchik S, White M, Kaur A
. Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults. Ann Allergy Asthma Immunol. 2013; 110(6):450-456.e4.
DOI: 10.1016/j.anai.2013.03.013.
View
13.
Frolund L, Durham S, Calderon M, Emminger W, Andersen J, Rask P
. Sustained effect of SQ-standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life. Allergy. 2009; 65(6):753-7.
DOI: 10.1111/j.1398-9995.2009.02238.x.
View
14.
Amar S, Harbeck R, Sills M, Silveira L, OBrien H, Nelson H
. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract. J Allergy Clin Immunol. 2009; 124(1):150-156.e1-5.
DOI: 10.1016/j.jaci.2009.04.037.
View
15.
Nadeau K, Schneider L, Hoyte L, Borras I, Umetsu D
. Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy. J Allergy Clin Immunol. 2011; 127(6):1622-4.
PMC: 3396422.
DOI: 10.1016/j.jaci.2011.04.009.
View
16.
Varshney P, Jones S, Scurlock A, Perry T, Kemper A, Steele P
. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol. 2011; 127(3):654-60.
PMC: 3060783.
DOI: 10.1016/j.jaci.2010.12.1111.
View
17.
Keet C, Frischmeyer-Guerrerio P, Thyagarajan A, Schroeder J, Hamilton R, Boden S
. The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol. 2011; 129(2):448-55, 455.e1-5.
PMC: 3437605.
DOI: 10.1016/j.jaci.2011.10.023.
View
18.
Blaiss M, Maloney J, Nolte H, Gawchik S, Yao R, Skoner D
. Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents. J Allergy Clin Immunol. 2011; 127(1):64-71, 71.e1-4.
DOI: 10.1016/j.jaci.2010.11.034.
View
19.
Boyce J, Assaad A, Burks A, Jones S, Sampson H, Wood R
. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010; 126(6 Suppl):S1-58.
PMC: 4241964.
DOI: 10.1016/j.jaci.2010.10.007.
View
20.
Fleischer D, Burks A, Vickery B, Scurlock A, Wood R, Jones S
. Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol. 2012; 131(1):119-27.e1-7.
PMC: 3550002.
DOI: 10.1016/j.jaci.2012.11.011.
View